Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice looser stools or diarrhoea in the days after stopping Mounjaro — and it can catch you off guard when you expected your gut to settle, not misbehave. As tirzepatide clears your system, the changes it made to gastric emptying and appetite signalling unwind, and that transition can produce a range of digestive symptoms after stopping, including diarrhoea. These medicines are prescription-only, and how your body responds when you stop is part of what a prescriber should be across. This page walks through what the evidence says, what calls for medical attention, and how to decide what to do next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide acts on two gut-hormone receptors (GIP and GLP-1) and one of its effects is to slow how quickly food moves from your stomach into the small intestine. While you're taking it, your digestive system adapts to this slower pace. Stop the injections, and that braking effect lifts. The gut doesn't always adapt smoothly in reverse. Faster gastric emptying can follow, and for some people that translates into loose stools or outright diarrhoea for a short period.
This isn't a sign that something has gone wrong with your gut itself. It's a physiological adjustment. The NHS tirzepatide medicines page lists diarrhoea among the common side effects during treatment; the same mechanisms that cause it during dose increases can produce a milder mirror image on stopping. Most people find the disruption resolves within one to two weeks. Staying well hydrated matters most during this window, dehydration from repeated loose stools can become a problem in its own right, particularly in warm weather or if you're also managing other health conditions.
If your symptoms started while you were still taking Mounjaro, the pattern on diarrhoea during Mounjaro treatment is slightly different and worth reading separately.
Most post-stopping diarrhoea is self-limiting and responds to standard gut-rest measures: bland food, fluids, avoiding alcohol and high-fat meals while things settle. Some situations call for more than that.
Seek same-day medical attention if you develop severe stomach pain, particularly pain that is persistent and radiates toward your back, with or without vomiting. This symptom pattern can indicate acute pancreatitis, a known but infrequent risk with GLP-1 medicines. The MHRA issued a Drug Safety Update in January 2026 specifically flagging pancreatitis as a serious side effect requiring urgent review; it applies to the period during treatment and the days immediately after stopping, while the medicine is still clearing. Don't wait to see if it passes.
Also speak to a doctor promptly if: diarrhoea is severe enough to make you feel dizzy or significantly dehydrated; there is blood in your stool; symptoms persist beyond two weeks without improving; or you develop a fever alongside gut symptoms. These don't automatically indicate something serious, but they warrant assessment rather than home management. A GP can rule out causes unrelated to Mounjaro, including infections or conditions that the appetite reduction during treatment may have masked.
If you've stopped Mounjaro and are now dealing with diarrhoea, you're probably weighing two questions: is this going to resolve on its own, and should I have stopped at all, or restarted?
On the first question: mild, improving diarrhoea in the first week or two after your last dose is generally part of the adjustment, and supportive measures (hydration, lighter meals, time) are reasonable. If symptoms are worsening rather than improving by day five or six, that's the point to call your GP rather than wait out another week.
On the restart or stop question, that's a clinical decision, not one to make based on how your gut is behaving this fortnight. Stopping Mounjaro is sometimes planned (after hitting a target or completing a course), sometimes abrupt (supply issues, costs, a planned procedure). The full picture of what stopping can involve includes more than gut symptoms. Equally, if diarrhoea has been persistent throughout your treatment and not after stopping, the pattern of diarrhoea that doesn't resolve on Mounjaro is a different clinical question. A prescriber is better placed than a search result to weigh those options for you specifically.
Our prescribers at nume discuss exactly these kinds of concerns (side effects, stopping, restarting, and whether treatment remains suitable) as part of the consultation. If you're considering starting or revisiting treatment, a free consultation is the right place to raise them. Mounjaro is a prescription-only medicine, and clinical oversight doesn't stop when the pen does.
You can also read more about Mounjaro's broader side-effect profile or look at constipation after stopping, which affects a different subset of people coming off treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.